Cátedra de Química Medicinal, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, (1113) Ciudad de Buenos Aires, Argentina.
Bioorg Med Chem. 2012 Oct 1;20(19):5986-91. doi: 10.1016/j.bmc.2012.07.028. Epub 2012 Jul 25.
New chiral purinyl and 8-azapurinyl carbanucleoside derivatives based on indanol were synthesized from commercial available (1S,2S)-trans-1-amino-2-indanol and (1R,2R)-trans-1-amino-2-indanol using a linear methodology. The antiviral activity and cytotoxicity of these compounds were evaluated against herpes simplex virus type 1 (HSV-1) in Vero cells, bovine viral diarrhea virus (BVDV) in Mardin-Darby bovine kidney (MDBK) cells and hepatitis B virus (HBV) in HepG2 2.2.15 cell line. Three compounds, showed an inhibition of the HBsAg levels similar to reference drug lamivudine. One chloropurinyl nucleoside, derived from the cis-1-amino-2-indanol, was cytotoxic on MDBK cells and it could be a lead for developing anticancer agents.
新型手性嘌呤基和 8-氮杂嘌呤基碳核苷衍生物基于吲哚醇,由商业可得的(1S,2S)-反式-1-氨基-2-吲哚醇和(1R,2R)-反式-1-氨基-2-吲哚醇通过线性方法合成。这些化合物的抗病毒活性和细胞毒性针对单纯疱疹病毒 1 型(HSV-1)在vero 细胞、牛病毒性腹泻病毒(BVDV)在 Mardin-Darby 牛肾(MDBK)细胞和乙型肝炎病毒(HBV)在 HepG2 2.2.15 细胞系进行了评估。三种化合物显示出与对照药物拉米夫定相似的抑制 HBsAg 水平。一种来源于顺式-1-氨基-2-吲哚醇的氯嘌呤核苷在 MDBK 细胞上具有细胞毒性,它可能是开发抗癌药物的先导化合物。